Ozempic (semaglutide) is increasingly prescribed for people with Type 2 diabetes who also have hypertension — a common combination. GLP-1 therapy actually lowers blood pressure modestly as a secondary effect, making it beneficial in this combination. But dietary management requires balancing GLP-1 nutritional priorities (high protein, nausea prevention) with hypertension dietary targets (low sodium, specific potassium management if on ACE inhibitors or ARBs).
What to Eat on Ozempic with Hypertension
- High-protein, low-sodium foods: fresh chicken, fish, egg whites, plain Greek yogurt — meet GLP-1 protein needs without the sodium load of processed high-protein options
- Low-sodium vegetables: the DASH diet emphasis on vegetables aligns with GLP-1 nutritional goals when low-potassium selections are chosen if also on ACE inhibitors or ARBs
- Small frequent meals: reduces nausea on Ozempic and keeps sodium loads per meal lower for hypertension management
- Magnesium-rich foods: nuts, seeds, leafy greens — support blood pressure reduction alongside the medication
Does Ozempic Lower Blood Pressure?
Yes — semaglutide produces modest blood pressure reductions as a secondary effect in clinical trials, independent of weight loss. The SUSTAIN and SELECT trials documented systolic blood pressure reductions of 3-6 mmHg on semaglutide. This beneficial effect means that people on antihypertensive medications who start Ozempic may eventually need dose reductions in their blood pressure medications as weight loss and the direct effect compound. Monitor blood pressure regularly after starting GLP-1 therapy and discuss medication adjustments with your physician.
Blood Pressure Medication Adjustments on Ozempic
Ozempic causes weight loss and has direct blood pressure-lowering effects. As weight decreases on GLP-1 therapy, blood pressure often improves — sometimes requiring dose reductions in antihypertensive medications to prevent hypotension (low blood pressure). If you are on ACE inhibitors or ARBs, the potassium-raising effect of those medications remains relevant regardless of Ozempic use. Monitor blood pressure at home and report significant drops to your physician — medication adjustment may be needed.
Clinical reference: The SELECT trial (semaglutide 2.4mg in people without diabetes, with established cardiovascular disease) showed significant cardiovascular mortality reduction and modest blood pressure lowering. ADA 2025 recommends GLP-1 agonists for patients with Type 2 diabetes and hypertension given the combined cardiovascular and blood pressure benefits.
Analyze Your Meals Against Your Conditions
Enter any food and Platelytix scores it against your medications, lab values, and conditions simultaneously.
Score a Meal Free →
⚕️ This page is for educational purposes only and does not constitute medical advice. Always consult your physician or registered dietitian before making dietary changes, especially when managing chronic conditions or taking medications.